OPHTHOTECH CORP.

Profile

Company Names

OPHTHOTECH CORP.

Addresses

5 VAUGHN DRIVE, SUITE 106, PRINCETON, NJ 08540

ONE PENN PLAZA, 35TH FLOOR, NEW YORK, NY 10119

Phone Numbers

609-945-6050
212-845-8200

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2007

State Incorporated:

DELAWARE

Total Amount Raised:

$46,066,565.00

Number of Funding Rounds:

7
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
7
2018-10-30 
$11,399,894.00 
$11,694,883.00 
$294,989.00 
Equity 
6
2013-05-23 
$16,666,668.00 
$50,000,000.00 
$33,333,332.00 
Equity 
5
2013-03-15 
$1.00 
$1.00 
$0.00 
 
4
2012-12-24 
$1.00 
$1.00 
$0.00 
 
3
2012-06-20 
$1.00 
$1.00 
$0.00 
 
2
2009-12-11 
$15,000,000.00 
$30,000,000.00 
$15,000,000.00 
Equity 
1
2009-10-14 
$3,000,000.00 
$3,000,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
THOMAS 
 
BIANCARDI 
EXECUTIVE OFFICER
ALEX 
 
BOLTE 
DIRECTOR
DAVID 
 
GUYER 
DIRECTOR, EXECUTIVE OFFICER
EVELYN 
 
HARRISON 
EXECUTIVE OFFICER
JANE 
PRITCHETT 
HENDERSON 
DIRECTOR
SAMIR 
C. 
PATEL 
EXECUTIVE OFFICER, DIRECTOR
DAVID 
 
REDLICK 
DIRECTOR
GLENN 
 
SBLENDORIO 
EXECUTIVE OFFICER, DIRECTOR
HENRY 
 
SIMON 
DIRECTOR
KEITH 
 
WESTBY 
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2018-10-30 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-05-23 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2013-03-15 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2012-12-24 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2012-06-20 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-12-11 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-10-14 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#